To elucidate the effect of involucrasin B on the TGFβ/SMAD2-3-4 pathway in the CRC cells, the Caco-2 cells were treated with different concentrations of involucrasin B (0, 12.5, 25, and 50 μM/mL). The gene discussed is SMAD2; the disease is colorectal carcinoma.